United States Federal Circuit

In a patent dispute concerning purified DNA molecules having promoter activity for the human involucrin gene, plaintiff's claims are unpatentable on the ground of anticipation.

Appellate Information

• Decided 12/21/2004
• Published 12/21/2004

Judges

• LOURIE, Circuit Judge., Before MAYER, Chief Judge, LOURIE and DYK, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellant:
  
• Peter G. Carroll, Medlen & Carroll, LLP, of San Francisco, California, argued for appellants.   With him on the brief was Thomas W. Brown., Mary L. Kelly, Associate Solicitor, United States Patent and Trademark Office, of Arlington, Virginia, argued for the Director of the United States Patent and Trademark Office.   With her on the brief were John M. Whealan, Solicitor, and William G. Jenks, Associate Solicitor.